Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 5/20 | 0.36 |
| ▸ | DRD3 | P35462 | 5/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3207675 | 0.75 | IDO1 (0.43) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL4701474 | 0.75 | IDO1 (0.43) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL16466650 | 0.68 | DRD2 (0.46) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL29941778 | 0.67 | DRD2 (0.44) | DRD2 | |
| SCHEMBL4666253 | 0.66 | DRD2 (0.53) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL22143868 | 0.66 | DRD2 (0.44) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL16033376 | 0.66 | DRD2 (0.44) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL1150855 | 0.66 | DRD2 (0.53) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL1154471 | 0.66 | DRD2 (0.44) | IDO1DRD2DRD3TRPM8CHRNB2 | |
| SCHEMBL17702023 | 0.66 | DRD2 (0.53) | IDO1DRD2DRD3TRPM8CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | ACHE, TYR, SGMS1 | IDO1 711/4885DRD2 4082/4885DRD3 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.